Etiology of Cleft Palate and its gene therapy

腭裂的病因学及其基因治疗

基本信息

  • 批准号:
    06671463
  • 负责人:
  • 金额:
    $ 1.47万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

Normal palate develops through the vertical growth, the bilateral elevation and fusion. We investigated expression of TGT beta and PTHrP in this fine process of the palate development using immunohistochemistry and in situ hybridization. Expression of both factors were recognized in the epithelium of palatal shelves and the mesenchymal condensation for bone. Concerning administration of Vitamine A induce cleft palate in pregnant rodents, reduction of PTHrP expression in embryonic facial tissue and decrease of DNA synthesis were also recognized from Vitamine A administration. However we could not show a good result of intra-amniotic administration of anti-sense S-oligo DNA for PTHrP.Although FITC-oligo was confirmed to be taken to the embryo, no remarkable change was observed. From now on, we would use organ culture, and attempt to elucidate the cleft-palate etiology.
正常腭的发育经历垂直生长、两侧抬高和融合。我们采用免疫组织化学和原位杂交技术研究了TGT β和PTHrP在腭发育过程中的表达。这两种因子的表达在腭突上皮和骨间充质凝聚中被识别。关于维生素A诱导妊娠啮齿动物腭裂的给药,也认识到维生素A给药可降低胚胎面部组织中PTHrP的表达和DNA合成。然而,我们不能显示羊膜内施用反义S-oligo DNA对PTHrP的良好结果。虽然证实FITC-oligo被带到胚胎中,但没有观察到显著变化。今后,我们将采用器官培养的方法,试图阐明腭裂的病因。

项目成果

期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tsukazaki T et al: "Expression of parathyroid hormone-related protein in rat articular cartilage" Cal Tissue Int. 57. 196-200 (1995)
Tsukazaki T 等人:“大鼠关节软骨中甲状旁腺激素相关蛋白的表达”Cal Tissue Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakashima M et al: "Expression of parathyroid hormone-related peptide in human thyroid tumors." JPathol. 175. 227-236 (1995)
Nakashima M 等人:“甲状旁腺激素相关肽在人类甲状腺肿瘤中的表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsukazaki T,Ohtsuru A,Enomoto H,Yano H,Motomura K,Ito M,Namba H,Iwasaki K,Yamashita S: "Expression of parathyroid hormone-related protein in rat articular cartilage" Cal Tissue Int. 57. 196-200 (1995)
Tsukazaki T,Ohtsuru A,Enomoto H,Yano H,Motomura K,Ito M,Namba H,Iwasaki K,Yamashita S:“大鼠关节软骨中甲状旁腺激素相关蛋白的表达”Cal Tissue Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Namba H et al: "Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thvroid cells." Cancer Res. 55. 2075-2080 (1995)
Namba H 等人:“辐射诱导的 G1 期停滞是由人类甲状腺细胞中的 p53-WAF1/Cip1 通路选择性介导的。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakashima M: "Expression of parathyroid hormone-related peptide in human thyroid tumors." J.Pathol.(in press). (1995)
Nakashima M:“甲状旁腺激素相关肽在人类甲状腺肿瘤中的表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJII Tohru其他文献

FUJII Tohru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJII Tohru', 18)}}的其他基金

Regeneration of the wound healing sites basing on the molecular analysis and the tissue-engineered
基于分子分析和组织工程的伤口愈合部位再生
  • 批准号:
    13307051
  • 财政年份:
    2001
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular biological analyses of wound healing process and application of the gene therapy
伤口愈合过程的分子生物学分析及基因治疗的应用
  • 批准号:
    11470373
  • 财政年份:
    1999
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Establishment of experimental model by using gene transfer and Leukemia Inhibitory Factor (LIF) "knock-out" mouse
基因转移和白血病抑制因子(LIF)“敲除”小鼠实验模型的建立
  • 批准号:
    09671502
  • 财政年份:
    1997
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The role of Transforming Growth Factor Beta signaling in vertebrate ocular development
转化生长因子β信号在脊椎动物眼部发育中的作用
  • 批准号:
    558493-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Transforming Growth Factor Beta-Activated Kinase 1 (Tak1) in Retinal Microglial Inflammation
转化生长因子 β 激活激酶 1 (Tak1) 在视网膜小胶质细胞炎症中的作用
  • 批准号:
    10438002
  • 财政年份:
    2022
  • 资助金额:
    $ 1.47万
  • 项目类别:
The role of Transforming Growth Factor Beta signaling in vertebrate ocular development
转化生长因子β信号在脊椎动物眼部发育中的作用
  • 批准号:
    558493-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Exploring the contribution of transforming growth factor beta signalling to natural killer cell impairment in the pathogenesis of experimental pulmonary arterial hypertension
探索转化生长因子β信号传导对实验性肺动脉高压发病机制中自然杀伤细胞损伤的贡献
  • 批准号:
    449650
  • 财政年份:
    2020
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Studentship Programs
Role of primary cilium in morphogen signalling modulation by Transforming Growth Factor-beta (TGF-beta) and its involvement in tissue fibrosis and abe
初级纤毛在转化生长因子-β (TGF-β) 形态发生素信号调节中的作用及其参与组织纤维化和 abe
  • 批准号:
    2272898
  • 财政年份:
    2019
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Studentship
A novel therapeutic approach to pulmonary arterial hypertension - targeting natural killer cells through the interleukin-15 and transforming growth factor-beta pathways.
一种治疗肺动脉高压的新方法 - 通过白细胞介素 15 和转化生长因子 β 途径靶向自然杀伤细胞。
  • 批准号:
    412482
  • 财政年份:
    2019
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Fellowship Programs
Transforming Growth Factor Beta as a causal factor in human osteoarthritis
转化生长因子β作为人类骨关节炎的致病因素
  • 批准号:
    nhmrc : 1138865
  • 财政年份:
    2018
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Project Grants
Transforming Growth Factor Beta as a causal factor in human osteoarthritis
转化生长因子β作为人类骨关节炎的致病因素
  • 批准号:
    nhmrc : GNT1138865
  • 财政年份:
    2018
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Project Grants
Cross-Talk between Transforming Growth Factor-beta and Periostin Can Be Targeted for Pulmonary Fibrosis
转化生长因子-β 和骨膜素之间的相互作用可以靶向治疗肺纤维化
  • 批准号:
    18K08144
  • 财政年份:
    2018
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapeutic potential of transforming growth factor-beta proteins for the diagnosis and treatment of female infertility
转化生长因子-β蛋白在诊断和治疗女性不孕症中的治疗潜力
  • 批准号:
    nhmrc : 1121504
  • 财政年份:
    2017
  • 资助金额:
    $ 1.47万
  • 项目类别:
    Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了